SCHEDULE 13D/A: Hercules Capital Management and Dr. Fen Zhang Disclose 21.4% Stake in Columbus Acquisition Corp
Schedule 13D Amendment
Hercules Capital Management VII Corp and its sole director, Dr. Fen Zhang, have filed an amended Schedule 13D, disclosing a beneficial ownership of 21.4% of Columbus Acquisition Corp's ordinary shares.
Summary
- Hercules Capital Management VII Corp (the "Sponsor") and Dr. Fen Zhang (collectively, the "Reporting Persons") beneficially own 1,698,290 Ordinary Shares of Columbus Acquisition Corp, representing approximately 21.4% of the Issuer's outstanding shares as of March 10, 2025.
- The total number of Ordinary Shares outstanding as of March 10, 2025, is 7,944,290.
- The Sponsor initially acquired 1,725,000 Ordinary Shares for an aggregate purchase price of $25,000 on March 21, 2024, which included 225,000 shares subject to forfeiture.
- Prior to the Issuer's initial public offering (IPO), the Sponsor transferred 36,000 Ordinary Shares to certain directors of the Issuer at its original purchase price.
- On January 24, 2025, simultaneously with the IPO, the Sponsor acquired an additional 234,290 units at $10.00 per unit, with each unit consisting of one Ordinary Share and one right.
- On March 10, 2025, the Sponsor forfeited 225,000 Ordinary Shares for no consideration, as the underwriters of the IPO did not exercise the over-allotment option within 45 days from the effective date of the Issuer's Registration Statement on Form S-1 (January 22, 2025).
Sentiment
Score: 7
Explanation: The document is primarily a factual disclosure of ownership. The maintenance of a significant 21.4% stake by the sponsor and its principal is a positive indicator of commitment, despite a pre-agreed share forfeiture.
Positives
- The Sponsor and its director maintain a significant beneficial ownership stake of 21.4% in Columbus Acquisition Corp, indicating continued commitment to the Issuer.
- The acquisition of additional units by the Sponsor at the IPO price demonstrates confidence in the Issuer's initial public offering.
Negatives
- The forfeiture of 225,000 Ordinary Shares by the Sponsor on March 10, 2025, due to the underwriters not exercising the over-allotment option, resulted in a reduction of the Sponsor's initial shareholding.
Risks
- The Reporting Persons may from time to time acquire additional Ordinary Shares or dispose of existing shares, which could impact the Issuer's stock price and ownership structure.
- The Issuer's future performance and strategic direction are subject to the successful completion of an initial business combination, as indicated by the rights attached to the acquired units.
Future Outlook
The Reporting Persons may, depending on prevailing market, economic, and other conditions, acquire additional Ordinary Shares or engage in discussions with the Issuer concerning future acquisitions of its shares. Such acquisitions could occur through open-market purchases, privately negotiated transactions, or direct acquisitions from the Issuer. The Reporting Persons currently have no other plans or proposals that would result in extraordinary corporate transactions, changes in the Board or management, material changes in capitalization or dividend policy, or other significant changes to the Issuer's business or corporate structure.
Management Comments
- Dr. Fen Zhang, as the sole director of Hercules Capital Management VII Corp, is deemed to hold voting and dispositive control over the securities held directly by the Sponsor.
- The Reporting Persons may consider acquiring additional shares of Columbus Acquisition Corp in the future, subject to market and economic conditions.
Industry Context
This filing is typical for a Special Purpose Acquisition Company (SPAC) where the sponsor plays a crucial role in the initial capitalization and ongoing ownership. The disclosure of a significant beneficial ownership stake by the sponsor and its principal is a standard transparency requirement, providing insight into the commitment of key stakeholders in the SPAC's lifecycle, particularly as it seeks to complete an initial business combination.
Legal Proceedings
- None of the Reporting Persons or, to their knowledge, the persons identified in Item 2, have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) in the past five years.
- None of the Reporting Persons or, to their knowledge, the persons identified in Item 2, have been a party to a civil proceeding resulting in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal and state securities laws in the past five years.
Related Party Transactions
- The Sponsor transferred 36,000 Ordinary Shares to certain directors of the Issuer at its original purchase price prior to the closing of the initial public offering, pursuant to a securities transfer agreement.
Stakeholder Impact
- Shareholders: The significant ownership stake by the Sponsor and its principal provides stability and alignment of interests, but potential future acquisitions or dispositions by the Reporting Persons could influence share price.
- Management/Board: The transfer of shares to certain directors indicates a direct relationship and alignment with the Sponsor.
Next Steps
- The Reporting Persons may acquire additional Ordinary Shares of the Issuer in the future.
- The Issuer's rights entitle holders to acquire one-seventh of one Ordinary Share at the completion of an initial business combination, indicating a future milestone for the company.
Key Dates
| Date | Description |
|---|---|
| March 21, 2024 | Date of the original Subscription Agreement under which the Sponsor acquired 1,725,000 Ordinary Shares. |
| July 25, 2024 | Amendment date for the Subscription Agreement. |
| November 8, 2024 | Date of the Securities Transfer Agreement between the Issuer, the Sponsor, and certain directors. |
| December 20, 2024 | Amendment date for the Securities Transfer Agreement and further amendment to the Subscription Agreement. |
| January 22, 2025 | Effective date of the Issuer's Registration Statement on Form S-1 (File No. 333-283278) and date of the Private Placement Units Purchase Agreement. |
| January 24, 2025 | Consummation date of the Issuer's initial public offering (IPO), simultaneously with which the Sponsor acquired 234,290 units. |
| March 10, 2025 | Date of event requiring the filing of this statement; date the Sponsor forfeited 225,000 Ordinary Shares; date as of which the total outstanding shares were calculated. |
| March 11, 2025 | Date of filing of the Schedule 13D Amendment and signing of the Joint Filing Agreement. |
Keywords
Columbus Acquisition Corp, Schedule 13D, Beneficial Ownership, Hercules Capital Management VII Corp, Fen Zhang, SPAC, Special Purpose Acquisition Company, Ordinary Shares, IPO, Private Placement, Share Forfeiture, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.